SLC26A4 and Graves disease: Here, peptide-based aAb assay have reported very high prevalence in different thyroid diseases, e.g. 84% of positive samples for the sodium-iodide symporter in Graves’ disease [42], or 97.5% positive samples for pendrin in Hashimoto’s disease [43].